Covis Pharma

Covis Pharma is a specialty pharmaceutical company headquartered in Zug, Switzerland, founded in 2011 by Dean J. Mitchell. The company focuses on marketing therapeutic solutions for patients facing life-threatening conditions and serious medical issues. It provides both branded and generic pharmaceutical products, as well as injectables, across various therapeutic areas including cardiovascular, central nervous system, oncology, and acute care. Covis Pharma's product portfolio includes medications such as ceftazidime, cefuroxime, digoxin, tranylcypromine sulfate, and ranitidine hydrochloride injection. In addition to its existing offerings, the company is dedicated to developing new therapeutic solutions aimed at enhancing the quality of life for patients in cardiology, psychiatry and neurology, oncology, and rheumatology sectors.

Ozgur Kilic

Global CFO

1 past transactions

AMAG Pharmaceuticals

Acquisition in 2020
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and commercializing therapeutics primarily for maternal and women’s health, as well as anemia management in the United States. The company’s key products include Feraheme, an intravenous iron replacement therapy for adults with iron deficiency anemia, particularly those intolerant to oral iron or with chronic kidney disease, and Makena, a hydroxyprogesterone caproate injection aimed at reducing the risk of preterm birth in women with a history of spontaneous preterm birth. Additionally, AMAG offers Intrarosa, a vaginal insert for treating dyspareunia due to menopause, and Vyleesi, an auto-injector for hypoactive sexual desire disorder in pre-menopausal women. The company is also advancing product candidates such as AMAG-423 for severe preeclampsia and Ciraparantag for anticoagulant reversal. Founded in 1981 and headquartered in Waltham, Massachusetts, AMAG Pharmaceuticals operates as a subsidiary of Covis Group S.à r.l. and generates most of its revenue from the sales of Feraheme and Makena.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.